Cargando…
In Vitro Characterization of the Neurapheresis™ System for the Treatment of Cryptococcal Meningitis
BACKGROUND: Cryptococcal Meningitis (CM) is the most common cause of fungal meningitis in adults. Treatment for CM is an induction, consolidation, and maintenance approach with antifungal agents. but is associated with continued high morbidity and mortality. Here we describe the in vitro characteriz...
Autores principales: | Charalambous, Lefko, Ballard, Christi, Ejikeme, Tiffany, Ashraf, Bilal, Pagadala, Promila, Giamberardino, Charles, Hedstrom, Blake, Verbick, Laura Zitella, Mccabe, Aaron, Lad, Shivanand P, Perfect, John R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631130/ http://dx.doi.org/10.1093/ofid/ofx163.1236 |
Ejemplares similares
-
Feasibility of Neurapheresis™ as a Therapy for Multidrug Resistant Gram-negative Bacterial Meningitis
por: Ballard, Christi, et al.
Publicado: (2017) -
Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastases
por: Ejikeme, Tiffany, et al.
Publicado: (2020) -
In vitro and numerical simulation of blood removal from cerebrospinal fluid: comparison of lumbar drain to Neurapheresis therapy
por: Khani, Mohammadreza, et al.
Publicado: (2020) -
Efficacy of Oral APX001 in a Murine Model of Cryptococcal Meningitis
por: Schell, Wiley A, et al.
Publicado: (2017) -
Cryptococcal meningitis presenting as acute onset bilateral cerebellar infarct
por: Mishra, Ajay Kumar, et al.
Publicado: (2017)